JenniferGaoMD

Breast Cancer, Hematologic Oncology

Medical Officer

Dr. Gao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

44 citations
Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an...
Lynn J. Howie, Harpreet Singh, Erik Bloomquist, Suparna Wedam, Laleh Amiri-Kordestani
Journal of Clinical Oncology. 2019-09-27
115 citations
Luminal A Breast Cancer and Molecular Assays: A Review
Jennifer Gao, Sandra M. Swain
The Oncologist. 2018-05-01
29 citations
U.S. FDA Drug Approvals for Breast Cancer - A Decade in Review.
Shaily Arora, Preeti Narayan, Christy Osgood, Suparna Wedam, Tatiana M. Prowell
Clinical Cancer Research. 2021-10-28

Lectures

How to Prepare Fellows for the Transition to Government
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
Benefit of CDK 4/6 inhibition in less common breast cancer subsets: A U.S. Food and Drug Administration pooled analysis.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018